Standard Life Aberdeen plc Buys 19,710 Shares of Humana Inc (HUM)

Standard Life Aberdeen plc boosted its stake in shares of Humana Inc (NYSE:HUM) by 9.0% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 237,593 shares of the insurance provider’s stock after acquiring an additional 19,710 shares during the quarter. Standard Life Aberdeen plc owned about 0.17% of Humana worth $58,959,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors also recently bought and sold shares of the company. Wells Fargo & Company MN lifted its position in Humana by 10.0% during the 3rd quarter. Wells Fargo & Company MN now owns 1,653,318 shares of the insurance provider’s stock worth $402,799,000 after acquiring an additional 150,173 shares during the period. Commonwealth Bank of Australia lifted its position in Humana by 3.9% during the 3rd quarter. Commonwealth Bank of Australia now owns 21,112 shares of the insurance provider’s stock worth $5,138,000 after acquiring an additional 796 shares during the period. Prudential Financial Inc. lifted its position in Humana by 53.6% during the 3rd quarter. Prudential Financial Inc. now owns 378,133 shares of the insurance provider’s stock worth $92,125,000 after acquiring an additional 131,990 shares during the period. Icon Advisers Inc. Co. lifted its position in Humana by 22.7% during the 3rd quarter. Icon Advisers Inc. Co. now owns 5,400 shares of the insurance provider’s stock worth $1,316,000 after acquiring an additional 1,000 shares during the period. Finally, Ameriprise Financial Inc. lifted its position in Humana by 10.8% during the 3rd quarter. Ameriprise Financial Inc. now owns 1,465,119 shares of the insurance provider’s stock worth $356,960,000 after acquiring an additional 142,706 shares during the period. 97.68% of the stock is owned by institutional investors.

Humana Inc (HUM) opened at $271.19 on Friday. Humana Inc has a one year low of $203.48 and a one year high of $293.35. The firm has a market capitalization of $38,740.00, a P/E ratio of 15.40, a P/E/G ratio of 1.45 and a beta of 0.93. The company has a quick ratio of 1.61, a current ratio of 1.85 and a debt-to-equity ratio of 0.48.

Humana (NYSE:HUM) last released its quarterly earnings data on Wednesday, February 7th. The insurance provider reported $2.06 earnings per share for the quarter, beating the consensus estimate of $2.00 by $0.06. Humana had a return on equity of 16.13% and a net margin of 4.55%. The firm had revenue of $13.19 billion during the quarter, compared to the consensus estimate of $13.14 billion. During the same period last year, the business posted $2.34 EPS. Humana’s quarterly revenue was up 2.4% on a year-over-year basis. equities analysts predict that Humana Inc will post 13.86 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 27th. Investors of record on Friday, March 30th will be paid a $0.50 dividend. This is an increase from Humana’s previous quarterly dividend of $0.40. This represents a $2.00 annualized dividend and a yield of 0.74%. The ex-dividend date is Wednesday, March 28th. Humana’s dividend payout ratio (DPR) is presently 9.09%.

Humana declared that its board has authorized a stock repurchase program on Thursday, December 14th that authorizes the company to buyback $3.00 billion in shares. This buyback authorization authorizes the insurance provider to reacquire shares of its stock through open market purchases. Shares buyback programs are usually a sign that the company’s board believes its stock is undervalued.

A number of analysts have weighed in on the company. Zacks Investment Research raised Humana from a “hold” rating to a “buy” rating and set a $294.00 price objective for the company in a research report on Monday, February 12th. JPMorgan Chase & Co. increased their price objective on Humana from $253.00 to $271.00 and gave the stock a “neutral” rating in a research report on Monday, February 12th. Deutsche Bank increased their price objective on Humana from $259.00 to $270.00 and gave the stock a “hold” rating in a research report on Friday, February 9th. Oppenheimer raised their price target on Humana from $275.00 to $305.00 and gave the company an “outperform” rating in a report on Thursday, February 8th. Finally, Leerink Swann raised their price target on Humana from $280.00 to $300.00 and gave the company an “outperform” rating in a report on Thursday, February 8th. Seven research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. The stock presently has an average rating of “Buy” and an average target price of $270.47.

In related news, VP Timothy S. Huval sold 1,382 shares of the firm’s stock in a transaction that occurred on Tuesday, December 19th. The stock was sold at an average price of $246.04, for a total value of $340,027.28. Following the completion of the transaction, the vice president now directly owns 11,557 shares of the company’s stock, valued at approximately $2,843,484.28. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Brian P. Leclaire sold 1,679 shares of the firm’s stock in a transaction that occurred on Thursday, December 21st. The shares were sold at an average price of $245.97, for a total value of $412,983.63. Following the completion of the transaction, the senior vice president now directly owns 9,888 shares of the company’s stock, valued at $2,432,151.36. The disclosure for this sale can be found here. Insiders sold a total of 10,115 shares of company stock valued at $2,501,627 over the last ninety days. 0.80% of the stock is currently owned by company insiders.

ILLEGAL ACTIVITY WARNING: “Standard Life Aberdeen plc Buys 19,710 Shares of Humana Inc (HUM)” was published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this story on another publication, it was illegally stolen and reposted in violation of United States & international copyright & trademark laws. The legal version of this story can be accessed at https://www.dispatchtribunal.com/2018/02/24/standard-life-aberdeen-plc-buys-19710-shares-of-humana-inc-hum.html.

About Humana

Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply